US tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal ...

Longer term, if the issues are not resolved, then for companies who are majority exports to the US there could be some issues ...

AstraZeneca’s Enhertu (trastuzumab deruxtecan) emerged as the highest-selling new drug in India in 2024, generating Rs 58 ...

Indian pharmaceutical and steel sectors show resilience against proposed US trade tariffs. Sun Pharma's Shanghvi indicates ...

The benchmarks, Nifty and Sensex, saw wild swings during the session, as attempts at recovery were thwarted by strong selling ...

Dilip Shanghvi, Founder and Managing Director of Sun Pharmaceutical Industries, has indicated potential plans to segment the company's operations into distinct verticals. This strategic consideration ...

OMD India will lead the strategic marketing and media efforts for the company's portfolio of OTC brands, including Lacto ...

Piramal Pharma has awarded its integrated media mandate to OMD India, part of Omnicom Media Group. Following a multi-round ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian ...